Synthesis, human topoisomerase IIα inhibitory properties and molecular modeling studies of anti-proliferative curcumin mimics.

Autor: Fawzy NG; Department of Pesticide Chemistry, National Research Centre Dokki Giza 12622 Egypt girgisas10@yahoo.com., Panda SS; Department of Chemistry & Physics, Augusta University Augusta GA 30912 USA., Fayad W; Drug Bioassay-Cell Culture Laboratory, Pharmacognosy Department, National Research Centre Dokki Giza 12622 Egypt., Shalaby EM; X-Ray Crystallography Lab., Physics Division, National Research Centre Dokki Giza 12622 Egypt., Srour AM; Department of Therapeutic Chemistry, National Research Centre Dokki Giza 12622 Egypt., Girgis AS; Department of Pesticide Chemistry, National Research Centre Dokki Giza 12622 Egypt girgisas10@yahoo.com.
Jazyk: angličtina
Zdroj: RSC advances [RSC Adv] 2019 Oct 21; Vol. 9 (58), pp. 33761-33774. Date of Electronic Publication: 2019 Oct 21 (Print Publication: 2019).
DOI: 10.1039/c9ra05661k
Abstrakt: 3,5-Bis(arylidene)- N -substituted-4-oxo-piperidine-1-carboxamides 24-51 were synthesized as curcumin mimics in a facile pathway through reaction of 3,5-bis(arylidene)-4-piperidones with the appropriate isocyanate in the presence of triethylamine. The 3 E ,5 E '-stereochemical configuration was conclusively supported by single crystal X-ray studies of compounds 25 and 34. Most of the synthesized piperidinecarboxamides showed high anti-proliferative properties with potency higher than that of 5-fluorouracil (clinically approved drug against colon, breast and skin cancers) through in vitro MTT bio-assay. Some of them revealed anti-proliferative properties at sub-micromolar values (IC 50 = 0.56-0.70 μM for compounds 29, 30 and 34-38 against HCT116; and IC 50 = 0.64 μM for compound 30 against A431 cell lines) with promising inhibitory properties against human DNA topoisomerase IIα. The safe profile of the anti-proliferative active agents against the RPE1 normal cell line may prove their selectivity towards carcinoma cells. Robust molecular models (2D-QSAR, 3D-pharmacophore) supported the SAR and validated the observed bio-properties.
Competing Interests: There is no conflict to declare.
(This journal is © The Royal Society of Chemistry.)
Databáze: MEDLINE